title: Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.
authors.affiliation: Creighton Diabetes Center, Omaha, NE 68131, USA. rendell@asndi.com
authors.forename: Marc
authors.initials: M
authors.lastname: Rendell
authors.forename: Steven G
authors.initials: SG
authors.lastname: Chrysant